Any document, written content or picture content posted onto the World Wide Web by NeoGenica BioScience Ltd. is entirely owned and under copyright protection of NeoGenica BioScience Ltd. The content may not be copied by anyone for commercial gain of any kind. The information may be copied by individual users for their personal reference, but these users may never reproduce, retransmit, re post, or republish this content in any way, and in any place, electronic or traditional, without the expressed written consent of Knightsbridge pharmaceuticals.
All of the content on this site is updated, and the company does make a reasonable effort to ensure that content is both accurate and current. None of the information or content on this site is endorsed or guaranteed by NeoGenica BioScience Ltd., and you access and use this information entirely at your own risk and own discretion.
NeoGenica BioScience Ltd., any person associated with the company, and any person associated with the designs or maintenance of this website, will not be held responsible or liable for any misuse of the terms of agreement. There can be no possibility of liability, punitive or other damages or costs for any consequences experienced by any user who uses this website. This website is solely an informational resource, and is never to be used as a substitute for a professional medical consultation, or professional medical advice. You should never self diagnose any medical condition.
All product names are protected under trademark and copyright law, whether appearing with a trademark symbol or not and whether in bold or normal font. Any un approved usage of any of these trademark protected names is in violation of the law, and other legislation and statutes. NeoGenica BioScience Ltd will prosecute aggressively, and to the full extent of possible law, and person or organization that infringes on the intellectual copyright of any of the content or information appearing on this site.
Genevatropin® is a pharmacy compounded product and is currently not approved bythe US Food and Drug Administration. Genevatropin® does not require a NDA or
ANDA by the FDA because of its current status as a compounded pharmaceutical.This site is for educational purposes only and not to be utilized as medical advice.